Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives

Archiv der Pharmazie

Volumn 341, Issue 4, 2008, Pages 209-215

  Palaska, Erhan ^a   Aydin, Firat ^a   Uçar, Gülberk ^a   Erol, Dilek ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

2 Pyrazoline; 4,5 Dihydro 1H pyrazole; MAO (Monoamine oxidase); Synthesis

Indexed keywords

1 THIOCARBAMOYL 3 (4 BROMOPHENYL) 5 (2 CHLORO 3,4 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE; 1 THIOCARBAMOYL 3 (4 BROMOPHENYL) 5 (3,4 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE; 1 THIOCARBAMOYL 3 (4 CHLOROPHENYL) 5 (2 CHLORO 3,4 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE; 1 THIOCARBAMOYL 3 (4 CHLOROPHENYL) 5 (3,4 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE; 1 THIOCARBAMOYL 3 (4 METHOXYPENYL) 5 (3,4 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE DERIVATIVE; 1 THIOCARBAMOYL 3 (4 METHOXYPHENYL) 5 (2 CHLORO 3,4 DIMETHOXYPENYL) 4,5 DIYDRO 1H PYRAZOLE DERIVATIVE; 1 THIOCARBAMOYL 3 (4 METHOXYPHENYL) 5 (2 CHLORO 3,4 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE; 1 THIOCARBAMOYL 3 (4 METHOXYPHENYL) 5 (3,4 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE; 1 THIOCARBAMOYL 3 (4 METHYLPHENYL) 5 (2 CHLORO 3,4 DIMETHOXYPHENYL) 4,5 DIHYDRO1H PYRAZOLE; 1 THIOCARBAMOYL 3 (4 METHYLPHENYL) 5 (3,4 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE; 1 THIOCARBAMOYL 3 PHENYL 5 (2 CHLORO 3,4 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE; 1 THIOCARBAMOYL 3 PHENYL 5 (3,4 DIMETHOXYPHENYL) 4,5 DIHYDRO 1H PYRAZOLE; 1 THIOCARBAMOYL 3,5 DIPHENYL 4,5 DIHYDRO 1H PYRAZOLE DERIVATIVE; 1,3 DIPHENYLPROPEN 1 ONE DERIVATIVE; ANTIDEPRESSANT AGENT; CELL EXTRACT; CLORGYLINE; MONOAMINE OXIDASE INHIBITOR; PARGYLINE; PROPYLENE; THIOSEMICARBAZIDE; UNCLASSIFIED DRUG; AMINE OXIDASE (FLAVIN CONTAINING); PYRAZOLE DERIVATIVE; THIOCARBAMIC ACID DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ELECTRON SPIN RESONANCE; ENZYME INHIBITION; ENZYME ISOLATION; ENZYME PURIFICATION; INFRARED SPECTROSCOPY; LIVER HOMOGENATE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; THROMBOCYTE; ANIMAL; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; ENZYMOLOGY; HUMAN; IN VITRO STUDY; INFRARED SPECTROPHOTOMETRY; LIVER; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; BLOOD PLATELETS; DRUG DESIGN; HUMANS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; PYRAZOLES; RATS; SPECTROPHOTOMETRY, INFRARED; STRUCTURE-ACTIVITY RELATIONSHIP; THIOCARBAMATES;

EID: 48949120100     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200700159     Document Type: Article

References (45)

1. J. Wouters, F. Moureau, G. Evrard, J. J. Koenig, et al., Bioorg. Med. Chem. 1999, 7, 1683-1693.
2. H. H. Stassen, J. Angst, A. Delini-Stula, Eur. Psychiatry 1998, 13, 128-133.
3. G. Curet, C. Dameiseau-Ovens, N. Sauvage, P. Sontag, P. Avenet, J. Affect. Disord. 1998, 51, 287-303.
4. F. Lotufo-Neto, M. Trivedi, M. E. Thase, Neuropsycopharmacology 1999, 20, 226-247.
5. M. B. H. Youdim, D. Edmondson, K. F. Tipton, Nat. Rev. Neurosci. 2006, 7, 295-309.
6. M. B. H. Youdim, Y. S. Bakhle, Br. J. Pharmacol. 2006, 147, S287-S296.
7. L. Oreland in Monoamine Oxidase: Basic and Clinical Aspects (Eds.: H. Yasuhara, S. H. Parvez, M. Sandler, K. Oguchi, T. Nagatsu), VSP Press, Utrecht, 1993, pp. 219-247.
8. M. Ebadi, S. Sharma, S. Shavali, H. El Rafaey, J. Neurosci. Res. 2002, 67, 285-289.
9. I. M. Anderson, Br. Med. Bull. 2001, 57, 161-178.
10. J. Knoll, Neurobiology 2000, 8, 179-199.
11. F. R. Souza, V. T. Souza, V. Ratzlaff, L. P. Borges, et al., Eur. J. Pharm. 2002, 451, 141-147.
12. M. N. A. Nasr, S. A. Said, Arch. Pharm. Pharm. Med. Chem. 2003, 336, 551-559.
13. P. Rani, V. K. Srivastava, A. Kumar, Eur. J. Med. Chem. 2004, 39, 449-452.
14. F. F. Barsoum, H. M. Hosni, A. S. Girgis, Bioorg. Med. Chem. 2006, 14, 3929-3937.
15. G. Turan-Zitouni, P. Chevallet, F. S. Kiliç, K. Erol, Eur. J. Med. Chem. 2000, 35, 635-641.
16. M. Bagheri, M. Shekarchi, M. Jorjani, M. H. Ghahremani, et al., Arch. Pharm. Pharm. Med. Chem. 2004, 337, 25-34.
17. B. S. Holla, P. M. Akberalli, M. K. Shivanada, Farmaco 2000, 55, 256-263.
18. D. Azarifar, M. Shaebanzadeh, Molecules 2002, 7, 885-895.
19. F. Chimenti, B. Bizzarri, F. Manna, A. Bolasco, et al., Bioorg. Med. Chem. Lett. 2005, 15, 603-607.
20. M. Abid, A. Azam, Bioorg. Med. Chem. 2005, 13, 2213-2220.
21. M. Abid, A. Azam, Eur. J. Med. Chem. 2005, 40, 935-942.
22. N. Soni, K. Pande, R. Kalsi, T. K. Gupta, et al., Res. Commun. Chem. Pathol. Pharmacol. 1987, 56, 129-132.
23. F. Manna, F. Chimenti, A. Bolasco, D. Secci, et al., Bioorg. Med. Chem. Lett. 2002, 12, 3629-3633.
24. N. Gökhan, A. Yesilada, G. Uçar, K. Erol, A. A. Bilgin, Arch. Pharm. Pharm. Med. Chem. 2003, 336, 362-371.
25. F. Chimenti, A. Bolasco, F. Manna, D. Secci, et al., J. Med. Chem. 2004, 47, 2071-2074.
26. F. Chimenti, E. Maccioni, D. Secci, A. Bolasco, et al., J. Med. Chem. 2005, 48, 7113-7122.
27. F. Chimenti, A. Bolasco, F. Manna, D. Secci, et al., Chem. Biol. Drug Des. 2006, 67, 206-214.
28. A. A. Bilgin, E. Palaska, R. Sunal, Arzneimittelforschung / Drug Res. 1993, 43, 1041-1044.
29. E. Palaska, M. Aytemir, I. T. Uzbay, D. Erol, Eur. J. Med. Chem. 2001, 36, 539543.
30. J. Wouters, F. Ooms, S. Jegham, J. J. Koenig, et al., Eur. J. Med. Chem. 1997, 32, 721-730.
31. W. Dawey, D. J. Tivey, J. Chem. Soc. 1958, 1320-1326.
32. H. S. Mehra, J. Ind. Chem. Soc. 1968, 45, 178-181.
33. A. Holt, D. F. Sharman, G. B. Baker, M. M. Pelcic, Anal. Biochem. 1997, 244, 384-392.
34. M. C. Anderson, F. Hasan, J. M. McCrodden, Neurochem. Res. 1999, 18, 1145-1149.
35. C. J. Fowler, K. F. Tipton, J. Pharm. Pharmacol. 1984, 30, 111-115.
36. A. W. C. Bach, N. C. Ian, D. L. Johnson, C. W. Abell, et al., Proc. Natl. Acad. Sci. 1998, 85, 4934-4938.
37. P. M. Yu, T. F. Tipton, A. A. Boultan, Prog. Brain. Res. 1995, 106, 8590.
38. C. Binda, P. Newton-Vinson, F. Hubalek, D. E. Edmondson, A. Mattevi, Nat. Struct. Mol. Biol. 2002, 9, 22-26.
39. C. Binda, A. Mattevi, D. E. Edmondson, J. Biol. Chem. 2002, 23973-23976.
40. D. E. Edmondson, C. Binda, A. Mattevi, Arch. Biochem. Biophys. 2007, 464, 269-276.
41. W. T. Harkcom, D. R. Bevan, Biochem. Biophys. Res. Commun. 2007, 360, 401-406.
42. N. Gökhan-Kelekçi, S. Yabanoglu, E. Küpeli, U. Salgin, et al., Bioorg. Med. Chem. 2007, 15, 5775-5786.
43. D. L. Murphy, C. Wright, M. Buchsbaum, A. Nichols, Biochem. Med. 1976, 16, 254-265.
44. G. Uçar, FABAD J. Pharm. Sci. 2002, 27, 149-156.
45. M. M. Bradford, Anal. Biochem. 1976, 72, 248-254.